跳至主要内容
临床试验/NCT04131257
NCT04131257Unknown不适用

Nurse-led Continuum of Care for People With Diabetes and Pre-diabetes in Nepal (NUCOD): Study Protocol for a Cluster Randomized Controlled Trial

Kathmandu University School of Medical Sciences0 个研究点目标入组 1,236 人开始时间: 2019年12月最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
1,236
主要终点
Change in Glycated Hemoglobin (HbA1c) level

研究概览

简要总结

The study aims to improve diabetes prevention, access to care and advocacy through a novel cost-effective nurse-led continuum of care approach that incorporates diabetes prevention, awareness, screening and management for low-income settings, and furthermore utilizes the endeavor to advocate for establishing standard diabetes program in Nepal.

详细描述

The purpose of this study will be to improve diabetes prevention, access to care and advocacy through a novel cost-effective nurse-led continuum of care approach that incorporates diabetes prevention, awareness, screening and management for low-income settings, and furthermore utilizes the endeavor to advocate for establishing standard diabetes program in Nepal.

We will conduct a two-arm, open-masked stratified cluster randomized controlled trial of a NUrse-led COntinuum of care for people with diabetes and pre-diabetes (NUCOD), with primary care centers (Outreach centers and Government health posts) as a unit of randomization. NUCOD will be delivered through the trained diabetes nurses in the community to the intervention group and the outcomes will be compared to the enhanced usual-treatment group at 6 and 12 months of the intervention. The primary outcome will be change in glycated hemoglobin (HbA1c) level among diabetes and progression to type 2 diabetes among pre-diabetes, and implementation outcomes measured using the RE-AIM (reach, effectiveness, adoption, implementation, and maintenance) framework. Outcomes will be analyzed on an intention to treat basis.

The results of this trial will provide information about the effectiveness of the NUCOD program in improving clinical outcomes for diabetes and pre-diabetes individuals, and implementation outcomes for the organization.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • with confirmed pre-existing type II diabetes and prediabetes at the time of our screening (i.e., pre-existing diabetes or prediabetes)
  • with confirmed diagnosis of type II diabetes or prediabetes after our community screening process (i.e., newly diagnosed diabetes and prediabetes)
  • is not planning to relocate outside of the current place of living in next 2 years
  • is older than 18 years of age

排除标准

  • are not psychologically capable of communication
  • are diagnosed as type 1 diabetes

研究组 & 干预措施

Continuum of care

Experimental

Trained diabetes nurses will provide continuum of care to the participants that includes: conducting community awareness campaigns, screening programs, linkage to clinical care, community follow-up counseling and support for individuals with diabetes, and prevention programs for individuals with pre-diabetes.

干预措施: Nurse-led Continuum of Care (Behavioral)

Usual care

Active Comparator

The control group will receive usual diabetic care without the nurse coordination and supervision as in the intervention group.

干预措施: Nurse-led Continuum of Care (Behavioral)

结局指标

主要结局

Change in Glycated Hemoglobin (HbA1c) level

时间窗: Baseline, 6 months, 12 months

The HbA1c will be measured using Boronate affinity chromatography (Axis-Shield, Norway)

Change in the incidence of diabetes among individuals with pre-diabetes

时间窗: 6 months, 12 months

Electronic Health Record will be used to measure the incidence of diabetes

次要结局

  • Change in the "Adoption at the patient level" measured by the Diabetes Treatment Satisfaction Questionnaire(Baseline, 6 months, 12 months)
  • Change in the "Adoption at the patient level" measured by the Summary of Diabetes Self-Care Activities Scale(Baseline, 6 months, 12 months)
  • Change in Blood Pressure(Baseline, 6 months, 12 months)
  • Change in lipid profile levels (HDL, LDL, Triglycerides, Total cholesterol)(Baseline, 6 months, 12 months)
  • Change in the "Reach" of people participating in the program(6 months, 12 months)
  • Change in the "Adoption at the clinic level"(6 months, 12 months)
  • Change in Body Mass Index(Baseline, 6 months, 12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Biraj Man Karmacharya

Associate Professor

Kathmandu University School of Medical Sciences

相似试验